Stocks of Sotera Health Co (NASDAQ:SHC) traded higher last session on Wall Street, down -4.55% to $11.13.
SHC stock price is now -12.84% away from the 50-day moving average and -19.78% away from the 200-day moving average. The market capitalization of the company currently stands at $3.16B.
With the price target of $14, Goldman recently initiated with Neutral rating for Sotera Health Co (NASDAQ: SHC). On May 21, 2024, Piper Sandler recently initiated its ‘Neutral’ rating on the stock quoting a target price of $13, while ‘Citigroup’ rates the stock as ‘Buy’
In other news, WARBURG PINCUS & CO., Director sold 15,000,000 shares of the company’s stock on Sep 06 ’24. The stock was sold for $225,450,000 at an average price of $15.03. Upon completion of the transaction, the Director now directly owns 73,822,952 shares in the company, valued at $821.65 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 06 ’24, Director WARBURG PINCUS & CO. sold 15,000,000 shares of the business’s stock. A total of $225,450,000 was realized by selling the stock at an average price of $15.03. This leaves the insider owning 73,822,952 shares of the company worth $821.65 million. A total of 46.24% of the company’s stock is owned by insiders.
During the past 12 months, Sotera Health Co has had a low of $10.71 and a high of $17.08. As of last week, the company has a debt-to-equity ratio of 5.81, a current ratio of 2.75, and a quick ratio of 2.48. According to the stock market information, the enterprise value for the company is $5227642368, which is based on a 71.58 price-to-earnings ratio, a 7.04 price-to-earnings-growth ratio, and a beta of 1.89. The fifty day moving average price for SHC is $12.7703 and a two-hundred day moving average price translates $13.8748 for the stock.
The latest earnings results from Sotera Health Co (NASDAQ: SHC) was released for 2024-12-31. The net profit margin was 4.03% and return on equity was 10.45% for SHC. The company reported revenue of $290.2 million for the quarter, compared to $310.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -6.46 percent.
